Sage Therapeutic Stock Target Price and Analyst Consensus
| SAGE Stock | USD 14.00 1.05 8.11% |
The current analyst and expert consensus on Sage Therapeutic is Buy with 16 hold recommendations. The current projected Sage Therapeutic target price consensus is 25.71 with 21 analyst opinions. One of the most common ways Sage Therapeutic analysts use to provide buy-or-sell recommendation to the public are conference calls analysis and financial statements evaluations. Some experts can also talk to Sage Therapeutic vendors, executives, and/or customers. Sage Therapeutic recommendation module provides expert sentiment on the projected Sage Therapeutic target price to derive its highest and lowest estimates based on target price standard deviation of 0.0. Check out Macroaxis Advice on Sage Therapeutic to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade Sage Stock refer to our How to Trade Sage Stock guide.
Lowest Forecast 23.4 | Highest Forecast 28.54 | Target Price 25.71 |
Sage |
It's important to approach Sage Therapeutic's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Sage Therapeutic price targets
Sage Therapeutic's stock target price is an estimate of its future price, usually made by analysts. Using Sage Therapeutic's target price to determine if it is a suitable investment can be done through the following steps:- Look at Sage Therapeutic's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Sage Therapeutic's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Sage Therapeutic Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Sage Therapeutic is a key component of Sage Therapeutic valuation and have some predictive power on the future returns of a Sage Therapeutic.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Sage Therapeutic's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Impulse Invested over 100 shares | |
 | Automobiles and Trucks Invested over 60 shares | |
 | Business Services Invested few shares | |
 | Banking Invested over 40 shares | |
 | Baby Boomer Prospects Invested over 40 shares | |
 | Manufacturing Invested over 40 shares | |
 | Momentum Invested few shares | |
 | Synthetics Invested over 100 shares | |
 | Chemicals Makers Invested over 500 shares |
Check out Macroaxis Advice on Sage Therapeutic to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade Sage Stock refer to our How to Trade Sage Stock guide.Note that the Sage Therapeutic information on this page should be used as a complementary analysis to other Sage Therapeutic's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Investment Finder module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for Sage Stock analysis
When running Sage Therapeutic's price analysis, check to measure Sage Therapeutic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sage Therapeutic is operating at the current time. Most of Sage Therapeutic's value examination focuses on studying past and present price action to predict the probability of Sage Therapeutic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sage Therapeutic's price. Additionally, you may evaluate how the addition of Sage Therapeutic to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |
The data published in Sage Therapeutic's official financial statements usually reflect Sage Therapeutic's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Sage Therapeutic. For example, before you start analyzing numbers published by Sage accountants, it's critical to develop an understanding of what Sage Therapeutic's liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Sage Therapeutic's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Sage Therapeutic's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Sage Therapeutic's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Sage Therapeutic. Please utilize our Beneish M Score to check the likelihood of Sage Therapeutic's management manipulating its earnings.